Devices & Diagnostics

NxThera Inc. raises $1 million for prostate device

NxThera Inc. has raised $1 million from the sale of equity and debt, according to documents filed with the Securities and Exchange Commission. The start-up, based in St. Paul, is developing ways to treat enlarged prostates by using vapor injections and thermal energy to kill tissue. CEO Robert Paulson formerly led Restore Medical Inc., a […]

By Thomas Lee on August 03, 2010

NxThera Inc. has raised $1 million from the sale of equity and debt, according to documents filed with the Securities and Exchange Commission.

The start-up, based in St. Paul, is developing ways to treat enlarged prostates by using vapor injections and thermal energy to kill tissue.

CEO Robert Paulson formerly led Restore Medical Inc., a company based in Roseville that focused on treating sleep apnea. Medtronic Inc. (NYSE: MDT) purchased Restore in 2008 for nearly $30 million.

Last December, NxThera raised $3 million from investors, including Arboretum Ventures, Aberdare Ventures, GDN Holdings, an investment firm run by former Medtronic vice chairman Dr. Glen Nelson.